Skip to content

Earnings yield at other companies

Abbott logo
AbbottABT
3.5%-2.4pp
DexCom logo
DexComDXCM
3.8%+1.9pp
Medtronic logo
MedtronicMDT
4.6%+0.3pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-7.2%-2.4pp
Embecta Corp. logo
Embecta Corp.EMBC
21.4%+14.3pp
Owlet logo
OwletOWLT
-31.8%+34.0pp

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Calculated from Senseonics Holdings, Inc. ’s reported figures.

Based on trailing twelve months.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's earnings yield?
Senseonics Holdings, Inc. (SENS) reported earnings yield of -31.3% in Q1 2026.
How has Senseonics Holdings, Inc. 's earnings yield changed year-over-year?
Senseonics Holdings, Inc. 's earnings yield decreased by 81.1% year-over-year, from -17.3% to -31.3%.
What is the long-term trend for Senseonics Holdings, Inc. 's earnings yield?
Over 4 years (2020 to 2025), Senseonics Holdings, Inc. 's earnings yield has grown at a -13.7% compound annual growth rate (CAGR), from -55.2% to -30.6%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.